Clinical Trials Browser

Phase 2/3 × Pathologic Complete Response × Metformin × Clear all

NCT06728982 2025-08-01

Impact Of Metformin In Rectal Cancer Patients

Phase 2/3 Completed

Pathologic Complete Response